INTRODUCTION
Mucosal barrier dysfunction and immune activation are associated with age-related fibrotic lung diseases, but environmental stimuli that incite these pathways remain largely uncharacterized (Travis et al., 2013; Rockey et al., 2015) . The abundant polysaccharide chitin, which is widely dispersed in both terrestrial and aquatic settings as a rigid, insoluble constituent of fungi, insects, helminths, and arthropods, is a candidate environmental insult that initiates innate immune cell activation when aspirated into the lung (Reese et al., 2007; Van Dyken et al., 2011 . Mammals express several family 18 glycosyl hydrolases, which in mice and humans include enzymatically inactive chi-lectins and two active chitinases, chitotriosidase (Chit1) and acidic mammalian chitinase (AMCase) (Chia1), an evolutionarily conserved secreted enzyme that is constitutively expressed in the lung and stomach and also highly induced during STAT6-dependent immune responses (Reese et al., 2007; Hussain and Wilson, 2013) . Elevated serum Chit1 is associated with Gaucher disease (Adrangi and Faramarzi, 2013) . Elevated AMCase was originally proposed to mediate reactive airways disease (Zhu et al., 2004) , but two separately generated AMCase transgenic mice exhibit normal lung function and do not develop lung disease (Reese et al., 2007; Fitz et al., 2012) . Rather, these mice remain resistant to epithelialand lymphoid-cell-mediated inflammatory injury in response to inhaled or aspirated chitin (Reese et al., 2007; Van Dyken et al., 2011 . Conversely, attenuation of chitinase or AMCase activity increases inflammatory cell accumulation and delays resolution after acute chitin challenge (Van Dyken et al., 2011; Fitz et al., 2012; Kim et al., 2015) , consistent with an enzymatic role for AMCase in the degradation of insoluble chitin polymers and suggesting that increased chitinolytic activity represents a conserved feedback mechanism to limit mucosal inflammatory responses in mammals.
Chitinases and chi-lectins are widely conserved throughout phylogeny, sharing similar protein domain architecture; in mammals, active chitinases are often present in multiple copies, arising from an initial duplication event of the ancestral enzyme that coincided with expansion of the vertebrate chitinase family (Hussain and Wilson, 2013) . In both mice and humans, genes encoding active chitinases AMCase and Chit1 are flanked by enzymatically inactive chi-lectins, several of which have been linked to inflammatory and fibrotic diseases by mechanisms that remain unclear; notably, a common 24-bp duplication in human CHIT1 results in the expression of an inactive enzyme with little evident phenotypic consequence, even in populations exposed to chitinrich foods and enteroparasites (Hussain and Wilson, 2013; Adrangi and Faramarzi, 2013; Manno et al., 2014; Sutherland et al., 2014; Zhou et al., 2014) . Considerable complexity underlies polysaccharide degradation in prokaryotes and eukaryotes, which can be coordinated by multimeric protein assemblies consisting of active enzymes and lectin-like binding proteins that support wide-ranging processes, including morphogenesis, nutrient acquisition, and innate immunity (Adrangi and Faramarzi, 2013; Smith and Bayer, 2013; Schwartzman et al., 2015) . Whether AMCase and/or Chit1 coordinate similar chitinolytic activities in the context of normal mammalian physiology, however, has remained unclear due to discrepancies in biochemical activity assays, conflicting reports, and lack of specific reagents and systems to track and characterize relevant cells and molecules.
Given the widespread distribution of chitin substrates in the environment, we sought to determine whether mammalian chitinases, such as AMCase and Chit1, function to mediate degradation and facilitate clearance of this ubiquitous insoluble polysaccharide at mucosal barriers under normal physiologic conditions. Here, using an AMCase knockin/knockout reporter mouse, we describe a population of lung epithelial cells that express AMCase necessary for chitin degradation in the airways, revealing a constitutive pathway important in clearing chitin oligomers and in preventing age-related fibrosis and decline in lung health. We present additional evidence that dysfunction of this homeostatic pathway may be relevant to other fibrotic lung diseases in mice and humans.
RESULTS

Airway Endochitinase Activity Is Mediated by AMCase-Expressing Epithelial Cells
To investigate the source and physiologic role of AMCase, we generated tandem dimer red fluorescent protein (tdTomato)-Cre knockin/knockout mice, termed ''ChiaRed'' (Figures 1A, S1A, and S1B). Two targeted ChiaRed clones were bred and characterized; homozygous ChiaRed (C/C) mice were born at Mendelian ratios and exhibited no obvious developmental abnormalities. We analyzed lymphoid and non-lymphoid tissues (lung, stomach, peritoneal cavity, spleen, and mesenteric lymph nodes) by flow cytometry and, although previous studies have suggested that AMCase is derived from macrophages (Zhu et al., 2004; Kim et al., 2015) , we observed no AMCase expression (as assessed by tdTomato) in CD45+ hematopoietic cells either at rest or after infection with Nippostrongylus brasiliensis (Nb), a migratory helminth that elicits a robust type 2 immune response associated with AMCase induction (Figures S1C-S1E; data not shown; Reese et al., 2007) . Among CD45À lung cells, however, we observed a population of AMCase-expressing cells that co-expressed the epithelial cell marker, EpCAM ( Figure 1B ). These cells localized to both conducting and distal airway epithelium and shared protein markers for secretory cells, including type 2 alveolar epithelial cells (surfactant protein C), but were distinct from Foxj1-expressing ciliated cells ( Figures 1C, S2A , and S2B). In confirmation of this lung expression pattern, Chia1 mRNA was detected in sorted CD45ÀEpCAM+ lung epithelial cells, but not in alveolar macrophages, which, in contrast, expressed high levels of Chil3, (G) Western blot analysis of AMCase protein levels (top) and chitinase activity (bottom) in BAL fluid from indicated mice in the steady state and 9 days after infection with Nippostrongylus brasiliensis (Nb). Numbers below blot indicate relative intensities by densitometry. R.U., relative units. Data in (B), (C), and (G) are representative of at least two independent experiments, and results from similar treatment groups were pooled in (G) and represent mean ± SEM; n = 3/group. *p < 0.01; **p < 0.001 (unpaired t test). See also Figures S1 and S2 and Table S1. encoding the chi-lectin Ym1 ( Figure 1D ). RNA sequencing (RNA-seq) analysis of sort-purified ChiaRed reporter-expressing lung epithelial cells from heterozygous mice also indicated significant enrichment of secretory cell marker genes (e.g., Scgb1a1, Scgb3a2, Cyp2f2, and Muc5b; Kotton and Morrisey, 2014) among ChiaRed+ epithelial cells as compared to unfractionated lung epithelial cells (CD45ÀEpCAM+) from wild-type mice; however, markers associated with distal alveolar cell types, such as Sftpc and Sftpb, were also highly expressed in both cell populations, albeit not differentially, indicating that AMCase is expressed by a subset of secretory lung epithelial cells, including club cells and type 2 alveolar cells, lining proximal and distal airways (Figure 1E ; Table S1 ).
Lung AMCase mRNA was absent in homozygous ChiaRed mice, whereas expression of chi-lectins remained normal; notably, the other mammalian chitinase capable of mediating endochitinase activity, chitotriosidase (Chit1), was not detected in lung tissue from wild-type, AMCase transgenic (lung-specific; surfactant protein C promotor-driven AMCase transgenic [SPAM]; Reese et al., 2007) or AMCase-deficient mice ( Figure 1F ). Consistent with this, AMCase, but not Chit1, protein was readily detected in bronchoalveolar lavage (BAL) fluid of wild-type mice but absent in homozygous ChiaRed mice ( Figures 1G and S2C) . Data are representative of at least two independent experiments, and results from similar treatment groups were pooled to represent mean ± SEM; n = 3-5 mice/group; *p < 0.01; **p < 0.001 (unpaired t test); in (F) as compared to similar uninfected group. See also Figure S2 .
Chitinase (chitobiosidase and chitotriosidase) activity in the BAL fluid, both in steady state and after Nb infection, was abolished in homozygous ChiaRed mice, whereas b-N-acetylglucosaminidase activity, which can be mediated by hexosaminidases, was unaffected ( Figures 1G and S2D ). Thus, epithelial AMCase mediates lung endochitinase activity in the steady state and after augmentation by type 2 cytokine signaling, consistent with prior findings in gene-targeted mice (Fitz et al., 2012) .
Constitutive AMCase Expression Is Independent of Type 2 Cytokine Signaling
The type 2 cytokines interleukin-4 (IL-4) and IL-13, along with their shared signaling adaptor STAT6, mediate AMCase induction in the lungs following type 2 immune challenges, such as allergens and helminths (Zhu et al., 2004; Reese et al., 2007) . We assessed whether the ChiaRed reporter allele was responsive to exogenous type 2 cytokine stimulation by administrating IL-13 into the airways of heterozygous ChiaRed mice. This treatment increased both the percentage of epithelial cells that expressed the ChiaRed reporter and the median fluorescence intensity (MFI) of tdTomato among reporter-expressing cells ( Figures 2A-2C) ; similar induction was also observed in ChiaRed reporter mice crossed to a lung-specific IL-13 transgene (data not shown). Airway chitinase activity in the steady state, however, was not dependent on either STAT6 or IL-4/13, and endochitinase activity in BAL fluid was normal in mice with genetic deficiencies in either STAT6 or IL-4/13 (Figure 2D) . Further, although ChiaRed reporter expression was highly induced in epithelial cells after Nb infection in a STAT6-and IL-4/ 13-dependent manner, consistent with prior lung expression data (Reese et al., 2007) , constitutive ChiaRed expression in these cells remained normal in the absence of type 2 cytokine signaling ( Figures 2E and 2F) . Thus, the ChiaRed reporter accurately reflects AMCase activity as based on prior reports.
Constitutive AMCase Maintains Lifespan and Lung Health with Aging
Although young mice maintained in standard barrier conditions exhibited no overt signs of disease, we noted spontaneous progressive health decline in a significant proportion of aging AMCase-deficient mice housed in standard barrier conditions, variably characterized by hunched posture, labored breathing, poor grooming/hair loss, skin lesions, and death ( Figure 3A ; moribund mice were euthanized as recommended by veterinary staff). In 12-month-old AMCase-deficient mice, oxygen saturation levels were significantly lower than in similarly aged wildtype controls, consistent with impaired lung function ( Figure 3B ). Analysis of lung tissue from 6-to 9-month-old AMCase-deficient mice revealed a pleomorphic accumulation of inflammatory immune cells, including group 2 innate lymphoid cells (ILC2s), gd T cells, CD4+ T cells, eosinophils, and neutrophils ( Figure 3C ), which resembled the profile of the lung cellular infiltrate induced after acute inhalation of purified chitin in wild-type mice (Van Dyken et al., 2014) . Although resident lung CD4+ T cells were elevated in aged ChiaRed homozygotes, the T cell receptor (TCR) Vb repertoire among these cells and serum immunoglobulin E (IgE) and IgG 1 antibody levels were unaffected by the absence of AMCase, suggesting that predominately innate immune pathways were dysregulated in the lungs of aging AMCase-deficient mice ( Figures 3D-3F ).
AMCase-Deficient Mice Develop Spontaneous Age-Related Lung Fibrosis Activation of resident lung ILC2s and gd T cells after chitin inhalation induces IL-13 and IL-17A production from these cells, respectively (Van Dyken et al., 2014) ; both cytokines have been implicated in the pathogenesis of lung fibrosis (Wilson et al., 2010) . We bred AMCase-deficient mice onto interferon g (IFNg)/IL-17A/IL-5/IL-13 cytokine reporter backgrounds Nussbaum et al., 2013; Liang et al., 2011) to assess the spontaneous expression of these cytokines among resident lung lymphocyte populations. We observed significantly increased percentages of lymphoid cells expressing these cytokines among CD4+ T cells, gd T cells, and ILC2s in the lungs of AMCase-deficient mice as compared to wild-type controls. Cytokine-expressing cells became more pronounced with age ( Figures 4A-4C ), a finding consistent with the mixed neutrophil and eosinophil infiltrates, and suggested that persistent cytokine-mediated immune stimulation contributed to chronic tissue alterations. Indeed, AMCase-deficient mice spontaneously developed age-related lung fibrosis, evidenced by increased subepithelial collagen deposition that was most prominent around conducting airways and vasculature ( Figure 4D ) but also accompanied by alveolar septal thickening and infiltration (Figures S3A and S3B) . Blinded histopathologic scoring of parenchymal changes using the Ashcroft scale (Hü bner et al., 2008) revealed higher fibrosis scores among 9-month-old AMCase-deficient animals as compared to age-matched wildtype mice ( Figure 4E ) and correlated with significantly increased lung hydroxyproline levels ( Figure 4F ). Aged AMCase-deficient animals also exhibited dysregulated immune responses to helminth infection, consistent with systemic inflammation (Finkelman et al., 1994) . Thus, intestinal clearance of Nb was delayed in older mice but unaffected in young AMCase-deficient mice as compared to littermate control wild-type mice, consistent with a separate study that did not examine the effects of age (Figures S4A-S4C; Vannella et al., 2016a) .
Chitin Accumulates Spontaneously in the Airways of Aged AMCase-Deficient Mice and Contributes to Fibrosis Chitin biopolymers are substrates for active chitinases and structurally related chi-lectins (Hussain and Wilson, 2013; Schimpl et al., 2012) . Whereas Ym1 protein, a STAT6-inducible chi-lectin genetically positioned near Chia1 and associated with lung inflammation (Sutherland et al., 2014), was present in BAL fluid, it was not altered in young or aged AMCase-deficient animals at rest or 10 days after infection with Nb ( Figure 5A ). Chitinase activity in the BAL fluid of AMCase-deficient animals, however, remained undetectable with age, revealing a nonredundant function for this enzyme ( Figure 5B ) and raising the possibility that altered chitin turnover in the airways contributed to age-related lung fibrosis. Indeed, BAL fluid isolated from AMCase-deficient mice at ages corresponding with fibrosis contained significantly elevated levels of spontaneously acquired chitin fragments than did wild-type controls, as assessed using a highly specific chitin-binding-domain (CBD)-containing probe ( Figure 5C ; Watanabe et al., 1994) . These chitin fragments likely derived from sources in the immediate environment of the mice. Consistent with this, we detected CBD-positive constituents sensitive to chitinase degradation in autoclaved plant-derived food and bedding materials used in the rodent barrier housing facility ( Figure 5D ), suggesting that, in aged AMCase-deficient mice, the inability to degrade ubiquitous, complex environmental sources of chitin mediates persistent epithelial stimulation, immune activation, and fibrosis.
To further test the direct effects of environmentally derived chitin, we administered extracts of house dust mite (Dermatophagoides farinae) and mold (Aspergillus niger), each of which contains chitin elements sensitive to chitinase degradation, to wild-type and AMCase-deficient mice (Figures S5A and S5B) . At times when wild-type mice resolved inflammation, AMCasedeficient mice retained significant accumulations of gd T cells, CD4+ T cells, neutrophils, and eosinophils ( Figure S5C ), supporting prior studies linking AMCase activity inversely with chitin levels and lung inflammation (Reese et al., 2007; Fitz et al., 2012; Van Dyken et al., 2011 Kim et al., 2015) and consistent with delayed resolution due to altered chitin clearance. Depletion of chitin from A. niger by pre-treatment with active chitinase reduced total BAL chitin levels in AMCase-deficient animals after challenge ( Figure S5D ), thus restoring the resolution of inflammation ( Figure S5E ), whereas challenge with purified chitin led to increased accumulation of gd T cells and neutrophils in the lungs of AMCase-deficient mice ( Figure S5F ). We also observed significantly higher numbers of lung ILC2s, gd T cells, and IL-17A-producing gd T cells in AMCase-deficient mice throughout the enhanced response to A. niger (Figures S5G and S5H) , consistent with increased activation of lymphoid cell populations and production of pro-fibrotic cytokines by persistent chitin-mediated injury.
To address whether restoration of lung chitinase activity was able to impact disease in the context of spontaneously accumulated environmental chitin fragments, we generated mice with lung-specific (surfactant protein C promoter-driven) transgenic expression of AMCase on a ChiaRed homozygous background (SPAM 3 CC). BAL chitobiosidase activity was robustly restored in SPAM 3 CC mice, to levels approximately 10-fold higher than in BAL collected from wild-type animals ( Figure 5E ). This restoration significantly reduced the levels of chitin polymers in the airways of 9-month-old SPAM 3 CC mice compared to co-housed littermate CC mice ( Figure 5F ). Remarkably, lung-specific transgenic AMCase restoration also ameliorated the inflammatory infiltrates and fibrosis in aged CC mice (Figures 5G and 5H) , consistent with a role for AMCase in mediating homeostatic degradation and turnover of immunostimulatory environmental chitin. To additionally test whether restoration of chitinase enzymatic activity was sufficient to ameliorate disease, we instilled recombinant Chit1 into the airways of aged AMCase-deficient mice repeatedly for 3 weeks. This regimen significantly elevated airway chitobiosidase activity for 48 hr after each dose, although this level remained below that of wild-type mice ( Figure 5I ). In agreement with the genetic chitinase restoration, treatment with Chit1 significantly reduced chitin polymer accumulation in the BAL of aged AMCase-deficient mice ( Figure 5J ), along with percentages of cytokine-expressing lymphoid cells, particularly IL-17-expressing CD4+ T cells and gd T cells, as well as IL-13-expressing ILC2s in the lungs of AMCase-deficient mice as compared to wild-type controls ( Figure 5K ). Furthermore, we observed a significant reduction in the hydroxyproline content of the lungs treated with Chit1 as compared to PBS ( Figure 5E ), Masson's trichrome-stained lung sections from 2-and 9-month old WT and C/C mice; scale bar represents 100 mm; a, airway; v, vessel. (E and F) Lung fibrosis score (E) and hydroxyproline (F) in lungs of WT and C/C mice. Data are representative of at least two independent experiments, and results from similar treatment groups were pooled to represent mean ± SEM; n = 6-13 mice/ group; *p < 0.01; **p < 0.001; ***p < 0.0001 (unpaired t test); as compared to age-matched WT control. See also Figures S3 and S4. Data are representative of at least two independent experiments, and results from similar treatment groups were pooled to represent mean ± SEM; n = 3-10/ group; *p < 0.05; **p < 0.01 (unpaired t test); compared as indicated or, in (C), to age-matched WT control. See also Figure S5 .
suggesting that abnormal chitin accumulation contributed to pro-fibrotic cytokine production and the severity of fibrosis, which was responsive to enzyme replacement therapy in the context of AMCase deficiency and aging.
Cytokine Signaling and Cellular Stress Pathways Induced in AMCase-Deficient Epithelium Homeostatic maintenance of the airways requires anticipatory production of enzymes, scavengers, and other factors moderating cellular stress pathways in response to periodic environmental insults, including exposures to pollutants, toxins, particulates, and endogenously produced reactive metabolites (Wolters et al., 2014; Sundar et al., 2015) . The abnormal accumulation of chitin particles and the development of fibrosis in aged AMCase-deficient mice suggested that disease was initiated by epithelial dysfunction. To identify molecular pathways altered in the absence of AMCase, we performed RNA-seq to compare the transcriptomes of ChiaRed-reporter-positive epithelial cells isolated from the lungs of 12-week-old heterozygous and homozygous mice, prior to the onset of lung fibrosis. Strikingly, 1,463 genes that were expressed at a level of >100 fragments per kilobase of exon per million mapped reads (FPKM) in either one of the cell populations were differentially expressed between C/+ and C/C epithelial cells (false discovery rate [FDR] < 0.05 ;  Table S2 ), indicating broad transcriptomic changes in the absence of AMCase. Pathway analysis indicated significant alterations between AMCase-deficient homozygous and heterozygous ChiaRed+ epithelial cells in a wide array of canonical pathways, including those involved in maintaining cellular integrity and cytokine signaling ( Figure 6A ; Table S3 ), revealing the induction of these pathways prior to the onset of fibrotic disease in AMCase-deficient animals. Gene sets belonging to pathways including NRF2-mediated oxidative stress responses (e.g., Nfe2l2, Fos, Actb, and Maff), unfolded protein responses (Xbp1 and Atf4), nuclear factor kappa B subunit 1 (NF-kB) signaling (Il33 and Nfkbib), telomerase signaling (Hsp90aa1 and Myc), and circadian rhythms (Per1, Per2, Cry1, and Cry2) were statistically overrepresented in AMCase-deficient cells as compared to heterozygous cells ( Figure 6B ). These results suggest that the inability to efficiently clear chitin particles from the airways initiates activation of epithelial cell stress pathways, inflammatory immune signaling, and dysregulation of homeostatic barrier function, all processes previously implicated in the development of lung fibrosis (Wolters et al., 2014; Sundar et al., 2015) .
The prominent cytokine signature that accompanied these early epithelial alterations led us to further test the persistent involvement of the type 2 cytokines IL-4, IL-5, and IL-13 in fibrotic disease associated with AMCase deficiency and aging. Chitin acutely induces IL-5 and IL-13 production from lung-resident ILC2 cells, which mediates eosinophilia in a manner partially dependent on the epithelial cytokine IL-33 (Van Dyken et al., 2014; Mohapatra et al., 2016) , and Il33 transcript was significantly elevated in AMCase-deficient cells from young mice (Figure 6B) . Although IL-5 deficiency eliminated the lung eosinophil accumulation in aged CC animals, this reduction had no effect on the lung fibrosis as measured by hydroxyproline content (Figures S6A-S6C ). In contrast, loss of IL-4 and IL-13 or their signaling adaptor STAT6 profoundly exacerbated fibrotic lung disease and death rates in aging CC animals ( Figures 6C and  6D ), indicating that certain type 2 cytokine-mediated pathways protect against severe lung injury, enhanced fibrosis, and death in the context of AMCase deficiency, consistent with a recent report documenting similar worsening in response to bleomycin-mediated lung injury among IL-13Ra1-deficient mice (KaroAtar et al., 2016) .
Human ILD Patients Accumulate Chitin Polymers in BAL Fluid
Age-related pulmonary fibrosis in humans can be associated with chronic exposure to insoluble particles, such as asbestos, silica, and beryllium, and recently, activated ILC2s were implicated in the pathogenesis (Hams et al., 2014) . We readily detected AMCase protein in BAL fluid from healthy human controls and patients with interstitial lung disease (ILD) (comprising idiopathic pulmonary fibrosis [IPF] or pulmonary fibrosis associated with scleroderma; Table S4 ) or asthma; as in the mouse, the other human chitinase, chitotriosidase, was not prevalent (Figures 7A and S7A) . We observed no difference in AMCase protein levels in BAL fluid between controls and patients with ILD or asthma ( Figures  7B and S7B ). AMCase activity can vary with common gene polymorphisms (Seibold et al., 2009; Aminuddin et al., 2012; Okawa et al., 2016) , but no differences in exo-or endochitinase activity were observed in BAL fluid between controls and patients with ILD; however, notably, human endochitinase activity in all but one patient sample was comparatively lower than in mouse BAL fluid and in contrast to normal b-N-acetylglucosaminidase activity ( Figure 7C ), supporting prior studies describing relatively inefficient enzymatic activity among common human AMCase isoforms (Seibold et al., 2009; Goedken et al., 2011; Okawa et al., 2016) . Further, as assessed using CBD-reactive material, significantly increased amounts of chitin polymers were present in BAL fluid from patients with ILD as compared to healthy controls ( Figure 7D ). This accumulation of chitin polymers was significant in patients with either IPF or pulmonary fibrosis associated with scleroderma and did not appear to be a generalized feature of lung inflammatory disorders, because the low level of chitin in the BAL fluid from patients with asthma did not differ from healthy controls ( Figures S7C and S7D) . In further support of this, mice that develop pulmonary fibrosis due to the conditional deletion of the protective telomere factor TRF-1 in alveolar type II cells (Povedano et al., 2015; Naikawadi et al., 2016 ) also accumulated chitin polymers in the airways with age ( Figure 7E ), indicating that induction of epithelial dysfunction alone was sufficient to impair chitin clearance from the airways. These data suggest that physiologic control of environmental chitin may not be maintained in the setting of abnormal fibrotic lung architecture and aging, perhaps reflecting impaired mucociliary clearance, cellular stress, or epithelial dysfunction in combination with low AMCase activity or the inability to induce endochitinase production to high levels similar to those invoked by robust type 2 immunity and STAT6-mediated repair pathways ( Figure 1G ).
DISCUSSION
Here, we show that AMCase is a constitutively secreted and nonredundant enzyme that mediates the clearance of environmental Figure S6 and Tables S2 and S3. chitin from healthy airways. In its absence, we observe significant morbidity and mortality in mice associated with accumulation of chitin polymers and persistent activation of immune cells and cytokines previously implicated in low-grade inflammation and fibrosis. Chitin is an insoluble biopolymer dispersed throughout the environment (Keyhani and Roseman, 1999) , including urban home environments (Van Dyken et al., 2011); individuals commonly have antibodies to ubiquitous chitin-associated allergens from insects and molds, consistent with widespread chitin exposure (Salo et al., 2014) . Reducing airway chitinase activity in mice alters the normal resolution of inflammation following challenge with complex biologic chitin-containing constituents, including house dust mite and fungal extracts (Van Dyken et al., 2011; Kim et al., 2015) , implicating a contributory inflammatory role for chitin, even in the presence of multiple other pattern recognition elements present in dust mite and fungal preparations. Our results suggest that chitin degradation by chitinase is a constitutive and essential process that maintains lung homeostasis, given that aged AMCase-deficient mice develop spontaneous lung fibrosis in association with activated cytokine and molecular pathways previously implicated in individuals plotted as single dots; n = 4-7/group. Lines in (B)-(D) represent mean value; **p < 0.01; ***p < 0.001 (unpaired t test); compared to healthy or similarly treated age-matched control. See also Figure S7 and Table S4. this process (Wilson et al., 2010; Wolters et al., 2014) . Therapeutic administration of exogenous chitinase to the airways reduced fibrosis in aged animals, suggesting that restoring the ability to clear or degrade naturally acquired chitin particles can ameliorate persistent stimulation of innate inflammatory pathways associated with chitin particle accumulation and lung disease. Acute inhalation of purified chitin particles initiates the epithelial cytokine-driven activation of resident lymphoid cells that orchestrate parallel pathways of IL-17-and IL-13-mediated inflammation associated with a mixed neutrophil and eosinophil infiltrate (Van Dyken et al., 2014) . Specialized AMCase-expressing lung epithelial cells, as revealed by the ChiaRed reporter mouse, are critical in mediating the degradation and clearance of the stimulus and thereby act as negative regulators of the persistent inflammatory pathways that mirror the pattern of cell and cytokine activation triggered by experimental acute chitin exposure in wild-type mice. Although the persistent lack of airway endochitinase activity in aged AMCase-deficient animals indicates that Chit1 does not compensate in this setting, replacement of chitinase activity by Chit1 administration to the airways of AMCase-deficient mice was sufficient to reduce chitin levels, ameliorate cytokine expression, and lessen fibrosis, highlighting the essential role for this specific enzymatic activity in the airways. Notably, similar patterns of inflammation to those induced by chitin occur in response to an array of lung epithelial tissue perturbations containing chitin, including helminth infection, dust mite, protease, and fungal exposures (Mohapatra et al., 2016; Van Dyken et al., 2016), and may contribute to lung fibrosis when dysregulated (Vannella et al., 2016b) . These stereotyped cytokine networks in response to lung injury may connect general pathways of epithelial dysfunction (oxidative stress, activation of UPR, and periodic cycling) with tissue inflammation that, in the case of AMCase deficiency, can be exacerbated by accumulation of particles normally cleared through enzymatic degradation or, in other pathologic settings, through impaired mucociliary function or anatomic disruption. A complex interplay between the epithelium and associated cytokines, however, was revealed by the exacerbation of the AMCase-deficiency phenotype in the absence of IL-4/IL-13 signaling, indicating that protective factors are simultaneously engaged in the context of immune stimulation.
Although AMCase expression in the steady state is required to prevent spontaneous disease associated with accumulation of chitin polymers, low levels of AMCase expression or activity in the context of fibrosis or aging may be unable to mediate efficient chitin clearance or degradation, as suggested by lower levels of chitin accumulation in airways of aged wild-type mice and the inability to clear chitin in the context of human ILD and mice with telomere dysfunction. In the latter cases, chitin may be an environmental driver that contributes to the exacerbation of underlying disease induced by epithelial dysregulation. Intriguingly, lung fibrosis due to AMCase deficiency appears to initially activate gene pathways mediating epithelial integrity that have been previously implicated in the setting of lung fibrosis (Wolters et al., 2014; Sundar et al., 2015) , suggesting that abnormal retention of chitin polymers in the airways instigates common epithelial stress pathways. For example, NRF2/glutathione-mediated oxidative stress responses in the lung are regulated by circadian rhythms (Pekovic-Vaughan et al., 2014) , which can be disrupted during lung inflammation Haspel et al., 2014) , supporting that chitin-particle-induced perturbations may instigate these same pathways in AMCase-deficient epithelial cells. In turn, epithelial dysfunction induced by unrelated means in aged individuals might also lead to increased retention of chitin polymers, perhaps by localized damage to epithelial cells that produce AMCase, impaired mucociliary clearance, or anatomic abnormalities, which all could contribute to the accumulation of chitin substrate beyond the degradative capacity of AMCase.
As established here using genetically deficient mice, AMCase is part of a non-redundant pathway for sustaining lung homeostasis, which is only apparent over time and in the presence of chitin substrate, perhaps reconciling other studies that have suggested a limited role for AMCase in lung pathologies (Vannella et al., 2016a; Fitz et al., 2012) . ILD is similarly a disease that is related to aging, in which the capacity to mediate clearance of chitin, and potentially other particles, may be compromised. Notably, whereas protein levels of AMCase in airway fluid remained normal in the context of fibrotic disease, human BAL fluid endochitinase activity was, in general, comparatively lower than that of mouse, suggesting that chitin clearance in healthy humans may occur more slowly than in other species or rely more on mucociliary activity to efficiently clear the insoluble particles. Although we did not detect Chit1 protein in the airways, other secreted airway proteins, such as surfactants, mucins, and enzymatically inactive chi-lectins, have been associated with lung inflammation and fibrosis (Sutherland et al., 2014; Zhou et al., Wolters et al., 2014) ; how these proteins might modulate or contribute to chitin-chitinase interactions in the airway lining fluid in health and disease remains to be unraveled. The expansion of chitinbinding chi-lectins at genetic loci where active chitinases reside in vertebrates (Hussain and Wilson, 2013) supports a model in which coordinate activities among these proteins are required to invade and process natural chitin-containing crystalline entities that impact in the lung, akin to the multi-component polysaccharide-processing proteins mobilized by bacteria to degrade cellulose (Smith and Bayer, 2013) . Nevertheless, our findings that AMCase is the predominant chitinase in human BAL fluid and that chitin polymers accumulate in the lungs of patients with ILD raise the possibility that chitin constitutes an environmental driver that might contribute to the progression of lung diseases of diverse etiologies as normal epithelial function becomes compromised with age. Further studies will be necessary to reveal whether targeting this process might impact the course of these devastating diseases.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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EXPERIMENTAL MODEL AND SUBJECT DETAILS Animal Studies
AMCase reporter mice (''ChiaRed'') were generated by homologous gene targeting in C57BL/6 embryonic stem cells, using a previously published cassette (Nussbaum et al., 2013) , which contains (in order from 5 0 to 3 0 ) genomic sequence of the rabbit b-globin gene partial exon 2-3, the gene encoding tdTomato (Clontech), encephalomyocarditis virus IRES, humanized Cre recombinase, bovine growth hormone poly(A), and a loxP-flanked neomycin resistance cassette. Homologous arms flanking the Chia1 translation initiation site (5 0 arm: 2866 base pairs (bp); 3 0 arm: 3081 bp) were amplified from C57BL/6 genomic DNA using Phusion polymerase (Finnzymes) and cloned into the cassette by standard methods. The construct was linearized with NotI and transfected by electroporation into C57BL/6 embryonic stem cells. Cells were grown on irradiated feeders with G418-containing media, and neomycinresistant clones were screened for 5 0 and 3 0 homologous recombination by PCR and Southern blot. Two clones were selected for injection into albino C57BL/6 blastocysts to generate chimeras, and males were bred with homozygous CMV-Cre transgenic C57BL/6 females [B6.C-Tg(CMV-Cre)1Cgn/J; The Jackson Laboratory] to excise the neomycin resistance cassette. Male and female C/+ heterozygous offspring were intercrossed to yield homozygous C/C ChiaRed mice. Primer sequences for genotyping ChiaRed mice were as follows: ChiaRed R (endogenous), 5 0 -GTGATGTGAGCTTAGAGAGCAAGA-3 0 , ChiaRed L2, 5 0 -GTCCTGACCACTTA GAAACCCTTA-3 0 ; ChiaRed R2, 5 0 -CATGGTGATACAAGGGACATCTTC-3 0 . Previously described mice included SFTPC promoterdriven AMCase transgenic on BALB/c background (SPAM; Reese et al., 2007) ; this transgene was re-injected into pronuclei of fertilized C57BL/6 ChiaRed heterozygous eggs to generate SPAM ChiaRed mice. Other mice included BALB/c, C57BL/6 (The Jackson Laboratory), Stat6 À/À (Kaplan et al., 1996) , Il4
last dose for analysis of lung immune cells by flow cytometry and collagen content as described below. Intranasal challenges with Aspergillus niger hyphal preparation and purified chitin (New England Biolabs; NEB) were performed as described (Van Dyken et al., 2011; Chitinase assays BAL fluid (10 ml) was incubated for 1 hr at 37 C, pH 5.0, protected from light, in the presence of N 0 ,N 00 -triacetylchitotriose substrates (0.5 mg/ml; Sigma) in 100 mL final volume assay buffer, for evaluation of b-N-glucosaminidase, chitobiosidase, or chitotriosidase activities, respectively. Reactions were stopped with sodium carbonate buffer and fluorescent signal was quantified using a FlexStation 3 (excitation 360 nm/emission 450 nm; Molecular Devices). Relative activity measurements were calculated after subtracting background values from wells containing substrate alone using a standard curve generated with serial dilutions of 4-methylumbelliferone. Chitinase from Trichoderma viride (Sigma) was used as a positive control and results from duplicate wells were averaged for all samples.
Tissue preparation and cell sorting Human BAL fluid was obtained using the standard approach (Goldstein et al., 1990 ) in a single sub-segment of either the right middle lobe or the lingula, with a total of 100 mL (for ILD cohort) or 200 mL (for asthma cohort) of sterile saline instilled, and similar returns among subject groups; analytes were normalized by volume. The BAL fluid was kept on ice and processed within 1 hr of collection, then frozen at À80 C until analysis. Mouse BAL fluid was collected by intratracheal installation of 1 mL sterile PBS, which was centrifuged for 5 min at 1600 rpm. Supernatants were removed and analyzed for chitinase activity, while the remaining 100 mL was heattreated at 95 C with intermittent shaking for 20 min, to lyse cellular material and denature protein elements prior to assaying for chitin content. Whole lungs were perfused with 20 mL PBS via heart puncture before preparing single-cell suspensions with an automated tissue dissociator (gentleMACS; Miltenyi Biotec).
For enumeration of lung immune infiltrates by flow cytometry, cells were prepared as described previously (Van Dyken et al., 2014) , using antibodies listed in Key Resources and gating as described in Figure S1C . For cell sorting and analysis of lung epithelial populations, cells were prepared by intratracheally instilling 2 mL dispase II (5 mg/ml, pre-warmed to 37 C) followed by instillation of 0.5 mL low-melting point agarose (ThermoFisher; 0.1% w/v in HBSS, pre-warmed) into lungs in situ, which were covered with a Kimwipe (Fisher) and cooled with ice for 1 min. The lungs were removed from the chest cavity, placed in 2 mL dispase II (5 mg/ml), incubated at room temperature for 45 min, then transferred to C tubes (Miltenyi) containing 5 mL DNase I solution (Roche; 25 mg/ml in HBSS). The lungs were dissociated by running gentleMACS program lung_01, then incubating at room temperature for 10 min with agitation, followed by program lung_02. The tissue was further dispersed by passing through 70 mm nylon filters, washed, and subjected to red blood cell lysis (PharmLyse; BD Biosciences) before final suspension and staining in PBS with 2% fetal calf serum for flow cytometry. Exclusion of DAPI (4',6-diamidine-2 0 -phenylindole dihydrochloride; Roche) identified live cells, which were enumerated with flow cytometric counting beads (CountBright Absolute; Life Technologies). Sample data were acquired using BD FACSDiva with a 4-laser LSRII or Fortessa flow cytometer (BD Biosciences) and analyzed using FlowJo software (Tree Star, Inc.). CD45-DAPI-EpCAM+ epithelial cells expressing the ChiaRed reporter as indicated were sorted to > 95% purity using a MoFlo XDP (Beckman Coulter).
Quantitative RT-PCR Total RNA was extracted from lung tissue as described (Mohapatra et al., 2016) . For sorted cells, alveolar macrophages (CD45+CD3-Thy1.2-CD11b-CD11c+Siglec F+) or epithelial cells (CD45-CD3-Thy1.2-CD11b-CD11c-Siglec F-EpCAM+) were lysed in RLT Plus and total RNA was eluted from RNeasy Plus Micro columns as recommended (QIAGEN). RNA concentration and purity was assessed with a spectrophotometer (NanoDrop; ThermoFisher) and equal amounts of total RNA were reverse transcribed with VILO cDNA Synthesis Kit prior to quantitative PCR (using DDCt) using the Power SYBR Green reagent on a StepOnePlus cycler (ThermoFisher). Primer sequences: 18s,
RNA-Seq
Epithelial cells (approximately 110,000 cells per mouse) were sorted from the lungs of 14 week-old wild-type (CD45-DAPI-EpCAM+) or ChiaRed homozygous and heterozygous reporter mice (CD45-DAPI-EpCAM+ChiaRed+), lysed in RLT media and processed using the miRNeasy Micro kit with on-column DNase treatment (QIAGEN). Total RNA quality was assessed by NanoDrop (Thermo) and the Agilent 2100 Bioanalyzer (Agilent Technologies). RNA sequencing libraries were generated using the Illumina TruSeq stranded mRNA kit, according to the manufacturer's protocol (Illumina). Library fragment size distributions were assessed using the Bioanalyzer 2100 and the DNA high-sensitivity chip. Library concentrations were measured using KAPA Library Quantification Kits (Kapa Biosystems), and equal amounts of indexed libraries were pooled and sequenced on the HiSeq 4000 (Illumina) from which $1.5 billion reads were obtained with an average read depth of 74.1 million reads/sample. Sequence alignment and splice junction estimation was performed using STAR (Dobin et al., 2013) . Mappings were restricted to those that were uniquely assigned to the mouse transcriptome, as provided by Ensembl (Flicek et al., 2014) and aggregated on a per-gene basis. These raw data were analyzed using DESeq2 (Anders and Huber, 2010) to assess variance and differential expression among all sorted epithelial cell samples (n = 18); specific comparisons shown in Figure 1 and Figure 7 represent averages calculated from biological replicates (wild-type, n = 3; ChiaRed homozygous, n = 2; ChiaRed heterozygous, n = 3). Among differentially expressed genes (false discovery rate < 0.05), 1463 genes that were expressed at a level of > 100 fragments per kilobase of exon per million mapped reads (FPKM) in either one of the cell populations were evaluated for pathway enrichment by Fisher's exact text right-tailed using Inginuity Pathway Analysis software (QIAGEN).
Protein and chitin assays BAL fluid (10 ml) proteins were separated by SDS-PAGE, transferred to PVDF membranes, probed with polyclonal anti-human/mouse AMCase (Abcam) or anti-human or anti-mouse Chit1 (R&D Systems), followed by biotinylated IgG secondary antibodies and streptavidin-HRP (Vector). Recombinant human or mouse Chit1 (R&D) and recombinant mouse AMCase (Reese et al., 2007) were used as positive controls. Standard ELISA was performed to determine levels of mouse Ym1 protein in BAL fluid (R&D) and serum IgG 1 (eBioscience) and IgE (BioLegend). Detection of chitin in BAL fluid was performed for each sample in duplicate using a previously described dot-blot assay (Van Dyken et al., 2011) . Briefly, 1 mL of BAL fluid was placed onto nitrocellulose membranes (GE Healthcare). Sonicated chitin (Sigma) was used as a positive control to generate a standard curve, from which relative values for each sample were calculated in order to compare separate blots. The membranes were covered and dried overnight at room temperature, rinsed in tris-buffered saline containing 0.05% Tween-20 (TBST), blocked with 5% bovine serum albumin (BSA) in TBST, and incubated with FITC-chitin-binding domain probe (CBD; New England Biolabs) in 1% BSA/TBST for 16 hr at 4 C with gentle rocking. After washing with TBST, the membranes were incubated with HRP-anti-fluorescein (Perkin Elmer) for 45 min at room temperature, washed and developed with ECL substrate (Thermo Scientific). Data from blots were acquired and analyzed with a ChemiDoc MP and Image Lab 5.1 software (BioRad). For hydroxyproline assays, snap-frozen whole lung tissue (10 mg) was homogenized in M tubes (Miltenyi) containing ice-cold ultrapure water (0.1 ml) by running gentleMACS program Protein_01 twice. Concentrated hydrochloric acid (12 M; 0.1 ml) was added, and samples were hydrolyzed for 3 hr at 120 C. Supernatants (50 ml) were transferred to 96-well microplates and wells were evaporated to dryness by incubating at 60 C for 20 hr. The concentration of hydroxyproline was determined by the reaction of oxidized hydroxyproline with 4-(dimethylamino)-benzaldehyde as recommended by the manufacturer (Sigma), measuring absorbance at 560 nm using a SpectraMax spectrophotometer (Molecular Devices).
Histology
For immunohistochemical staining of tdTomato in ChiaRed lungs, samples were fixed in 4% paraformaldehyde, immersed in 30% sucrose, and embedded in OCT compound (Sakura Finetek) prior to frozen sectioning at 6 mm using a Leica CM 3050S cryomicrotome (Leica Microsystems). Amplification of tdTomato fluorescence in ChiaRed mice was achieved using polyclonal anti-dsRed (Clontech) followed by anti-rabbit-A555 (Thermo), and in combination with anti-EpCAM-AF488 (BioLegend), anti-SPC-FITC (LSBio), or anti-Foxj1 (eBioscience) using mouse blocking reagent (Vector). Masson's trichrome stain was performed by the UCSF Anatomic Pathology Clinical Laboratory on paraffin-embedded lungs fixed in 4% paraformaldehyde. Images were acquired with an AxioCam HRm camera and AxioImager M2 upright microscope (Carl Zeiss).
QUANTIFICATION AND STATISTICAL ANALYSES
Statistical analysis
Statistical analysis for RNA-seq data is described above. Data in all figures represent mean ± SEM unless otherwise indicated, and results from independent experiments were pooled when possible. Data were analyzed using Prism (GraphPad), using unpaired twotailed Student's t tests; significance was defined as indicated in figure legends.
DATA AND SOFTWARE AVAILABILITY
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The accession number for the RNA-seq data reported in this paper is GEO: GSE97196. 
